Insights

New HIPAA Final Rule: Key Changes to Reproductive Health Care Privacy

The DEA Is Knocking at Your Door . . . Are You Prepared?

The Future of Laboratory Testing Just Got a Little Clearer: FDA's Final Rule on LDTs

If Cannabis Is Reclassified, What Will Happen to the Marketplace?

FDA Releases Laboratory-Developed Tests Final Rule

Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs

Post-Dobbs: One Year Later

Managing Trade Secrets and Restrictive Covenants in Health Care M&A Deals

Inflation Reduction Act’s Drug Price Negotiation Provisions – What’s Next?

Direct Access Laboratory Testing: Physician Orders and Specimen Collection

Legal and Regulatory Landscape for Psychedelics as Therapies

The End of the Public Health Emergency – What’s to Come?

Direct Access Laboratory Testing: Reimbursement & Compliance

Direct Access Laboratory Testing: Navigating the Regulatory Landscape

2023 Health Policy Outlook

Post-Dobbs: Access to Reproductive Health Care and Abortion-Inducing Drugs

Post-Dobbs: Navigating the Fast-Changing and Uncertain Legal Landscape

Health Care's Past, Present, and Future

Hot Areas in COVID-19 Enforcement, Testing, and Funding

Impact of COVID-19 on Pharmacist Scope of Practice: Before and After the PREP Act

Record-Shattering Year for FCA Recoveries in Health Care

Career Pathways: Welcome to Epstein Becker Green – Columbus Ohio Team

Federal and State Cannabis Rules Are Moving in Different Directions

COVID-19 Vaccines: The Ethical and Legal Challenges to Immunization

Key Considerations for Reshoring U.S. Drug Manufacturing

Health Care Continues to Drive False Claims Act Recoveries: Thought Leaders in Health Law Video Series

Trends and Legal Risks in Medical Marijuana: Thought Leaders in Health Law Video Series

Trends in Drug Pricing and Reimbursement: Thought Leaders in Health Law Video Series